no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Bayesian Networks: A New Approach to Predict Therapeutic Range Achievement of Initial Cyclosporine Blood Concentration After Pediatric Hematopoietic Stem Cell Transplantation
|
Leclerc, Vincent |
|
2018 |
18 |
1 |
p. 67-75 |
article |
2 |
Bayesian Networks: A New Approach to Predict Therapeutic Range Achievement of Initial Cyclosporine Blood Concentration After Pediatric Hematopoietic Stem Cell Transplantation
|
Leclerc, Vincent |
|
|
18 |
1 |
p. 67-75 |
article |
3 |
Bioavailability of Orally Administered Des-Aspartate-Angiotensin I in Human Subjects
|
Lee, Kok-Onn |
|
2017 |
18 |
1 |
p. 51-54 |
article |
4 |
Bioavailability of Orally Administered Des-Aspartate-Angiotensin I in Human Subjects
|
Lee, Kok-Onn |
|
|
18 |
1 |
p. 51-54 |
article |
5 |
Comparison of the Pharmacokinetics of Droxidopa After Dosing in the Fed Versus Fasted State and with 3-Times-Daily Dosing in Healthy Elderly Subjects
|
Chen, Jack J. |
|
2018 |
18 |
1 |
p. 77-86 |
article |
6 |
Comparison of the Pharmacokinetics of Droxidopa After Dosing in the Fed Versus Fasted State and with 3-Times-Daily Dosing in Healthy Elderly Subjects
|
Chen, Jack J. |
|
|
18 |
1 |
p. 77-86 |
article |
7 |
Effects of a Fixed-Dose Co-Formulation of Daclatasvir, Asunaprevir, and Beclabuvir on the Pharmacokinetics of a Cocktail of Cytochrome P450 and Drug Transporter Substrates in Healthy Subjects
|
Garimella, Tushar |
|
2017 |
18 |
1 |
p. 55-65 |
article |
8 |
Effects of a Fixed-Dose Co-Formulation of Daclatasvir, Asunaprevir, and Beclabuvir on the Pharmacokinetics of a Cocktail of Cytochrome P450 and Drug Transporter Substrates in Healthy Subjects
|
Garimella, Tushar |
|
|
18 |
1 |
p. 55-65 |
article |
9 |
Efficacy and Safety of Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis: An Update
|
Rodríguez-Portal, José Antonio |
|
2017 |
18 |
1 |
p. 19-25 |
article |
10 |
Efficacy and Safety of Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis: An Update
|
Rodríguez-Portal, José Antonio |
|
|
18 |
1 |
p. 19-25 |
article |
11 |
Intranasal Therapy to Stop Status Epilepticus in Prehospital Settings
|
Benfield, John |
|
2017 |
18 |
1 |
p. 7-17 |
article |
12 |
Intranasal Therapy to Stop Status Epilepticus in Prehospital Settings
|
Benfield, John |
|
|
18 |
1 |
p. 7-17 |
article |
13 |
In Vitro Safety Pharmacology Profiling of Topical α-Adrenergic Agonist Treatments for Erythema of Rosacea
|
Piwnica, David |
|
2018 |
18 |
1 |
p. 87-90 |
article |
14 |
In Vitro Safety Pharmacology Profiling of Topical α-Adrenergic Agonist Treatments for Erythema of Rosacea
|
Piwnica, David |
|
|
18 |
1 |
p. 87-90 |
article |
15 |
Sealing Effects on the Storage Stability of the Cyanide Antidotal Candidate, Dimethyl Trisulfide
|
Kiss, Lóránd |
|
2017 |
18 |
1 |
p. 45-49 |
article |
16 |
Sealing Effects on the Storage Stability of the Cyanide Antidotal Candidate, Dimethyl Trisulfide
|
Kiss, Lóránd |
|
|
18 |
1 |
p. 45-49 |
article |
17 |
Second-Hand Exposure of Staff Administering Vaporised Cannabinoid Products to Patients in a Hospital Setting
|
Solowij, Nadia |
|
2018 |
18 |
1 |
p. 41-44 |
article |
18 |
Second-Hand Exposure of Staff Administering Vaporised Cannabinoid Products to Patients in a Hospital Setting
|
Solowij, Nadia |
|
|
18 |
1 |
p. 41-44 |
article |
19 |
The Risk of Thrombocytopenia During Valproic Acid Therapy: A Critical Summary of Available Clinical Data
|
Buoli, Massimiliano |
|
2017 |
18 |
1 |
p. 1-5 |
article |
20 |
The Risk of Thrombocytopenia During Valproic Acid Therapy: A Critical Summary of Available Clinical Data
|
Buoli, Massimiliano |
|
|
18 |
1 |
p. 1-5 |
article |
21 |
15 Years of Experience with Biphasic Insulin Aspart 30 in Type 2 Diabetes
|
Liebl, Andreas |
|
2018 |
18 |
1 |
p. 27-39 |
article |
22 |
15 Years of Experience with Biphasic Insulin Aspart 30 in Type 2 Diabetes
|
Liebl, Andreas |
|
|
18 |
1 |
p. 27-39 |
article |